VYST Stock Overview
Vystar Corporation manufactures and sells air purifiers in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Vystar Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.008 |
| 52 Week High | US$0.70 |
| 52 Week Low | US$0.000001 |
| Beta | -11.37 |
| 1 Month Change | -79.11% |
| 3 Month Change | -77.78% |
| 1 Year Change | -85.45% |
| 3 Year Change | -99.73% |
| 5 Year Change | -99.82% |
| Change since IPO | -99.99% |
Recent News & Updates
Recent updates
Shareholder Returns
| VYST | US Chemicals | US Market | |
|---|---|---|---|
| 7D | 45.5% | 0.3% | 1.2% |
| 1Y | -85.5% | 8.9% | 24.7% |
Return vs Industry: VYST underperformed the US Chemicals industry which returned 8.9% over the past year.
Return vs Market: VYST underperformed the US Market which returned 24.7% over the past year.
Price Volatility
| VYST volatility | |
|---|---|
| VYST Average Weekly Movement | 96.0% |
| Chemicals Industry Average Movement | 5.3% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: VYST's share price has been volatile over the past 3 months.
Volatility Over Time: VYST's weekly volatility has decreased from 46722% to 97% over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 5 | n/a | www.vystarcorp.com |
Vystar Corporation manufactures and sells air purifiers in the United States. The company offers RXair, a residential filterless air purifier; RX400, a food and drug administration (FDA) cleared class II filterless air purifier; and RX3000, a commercial FDA cleared class II air purifier. It also manufactures and sells Vytex natural rubber latex products to the manufacturers of rubber and rubber end products; and manufacturers of a range of consumer and medical products, such as adhesives, gloves, balloons, condoms, and other medical devices, as well as natural rubber latex foam mattresses, toppers, and pillows.
Vystar Corporation Fundamentals Summary
| VYST fundamental statistics | |
|---|---|
| Market cap | US$106.33k |
| Earnings (TTM) | -US$1.14m |
| Revenue (TTM) | US$417.42k |
0.3x
P/S Ratio-0.1x
P/E RatioIs VYST overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| VYST income statement (TTM) | |
|---|---|
| Revenue | US$417.42k |
| Cost of Revenue | US$475.03k |
| Gross Profit | -US$57.61k |
| Other Expenses | US$1.08m |
| Earnings | -US$1.14m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.086 |
| Gross Margin | -13.80% |
| Net Profit Margin | -273.58% |
| Debt/Equity Ratio | -25.9% |
How did VYST perform over the long term?
See historical performance and comparison